Page last updated: 2024-10-31

methylphenidate and Fragile X Syndrome

methylphenidate has been researched along with Fragile X Syndrome in 4 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Fragile X Syndrome: A condition characterized genotypically by mutation of the distal end of the long arm of the X chromosome (at gene loci FRAXA or FRAXE) and phenotypically by cognitive impairment, hyperactivity, SEIZURES, language delay, and enlargement of the ears, head, and testes. INTELLECTUAL DISABILITY occurs in nearly all males and roughly 50% of females with the full mutation of FRAXA. (From Menkes, Textbook of Child Neurology, 5th ed, p226)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wrenn, CC1
Heitzer, AM1
Roth, AK1
Nawrocki, L1
Valdovinos, MG1
Thomson, A1
Maltezos, S1
Paliokosta, E1
Xenitidis, K1
Rueda, JR1
Ballesteros, J1
Tejada, MI1
Hagerman, RJ1
Miller, LJ1
McGrath-Clarke, J1
Riley, K1
Goldson, E1
Harris, SW1
Simon, J1
Church, K1
Bonnell, J1
Ognibene, TC1
McIntosh, DN1

Reviews

2 reviews available for methylphenidate and Fragile X Syndrome

ArticleYear
Amfetamine for attention deficit hyperactivity disorder in people with intellectual disabilities.
    The Cochrane database of systematic reviews, 2009, Jan-21, Issue:1

    Topics: Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child

2009
Systematic review of pharmacological treatments in fragile X syndrome.
    BMC neurology, 2009, Oct-13, Volume: 9

    Topics: Acetylcarnitine; Dioxoles; Folic Acid; Fragile X Syndrome; Humans; Methylphenidate; Piperidines; Tre

2009

Other Studies

2 other studies available for methylphenidate and Fragile X Syndrome

ArticleYear
Effects of clonidine and methylphenidate on motor activity in Fmr1 knockout mice.
    Neuroscience letters, 2015, Jan-12, Volume: 585

    Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Attention Deficit Disorder with Hyperactivity; Centra

2015
Influence of stimulants on electrodermal studies in Fragile X syndrome.
    Microscopy research and technique, 2002, May-01, Volume: 57, Issue:3

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child;

2002